Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer’s Disease: In Vitro and In Vivo Evidence

Astrocyte dysfunction in Alzheimer disease

(2017) Crystal Acosta et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Neurotoxic reactive astrocytes are induced by activated microglia

(2017) Shane A. Liddelow et al.   NATURE

Aberrant iPSC-derived human astrocytes in Alzheimer's disease

(2017) V C Jones et al.   Cell Death & Disease

Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease

(2017) Sid E. O'Bryant et al.   JOURNAL OF ALZHEIMERS DISEASE

Reactive gliosis in the pathogenesis of CNS diseases

(2016) Milos Pekny et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations

(2016) Stefania Petrosino et al.   BRITISH JOURNAL OF PHARMACOLOGY

Astroglia dynamics in ageing and Alzheimer's disease

(2016) Alexei Verkhratsky et al.   CURRENT OPINION IN PHARMACOLOGY

Safety of micronized palmitoylethanolamide (microPEA): lack of toxicity and genotoxic potential

(2016) Earle R. Nestmann   Food Science & Nutrition

Analysis of motor function in 6-month-old male and female 3xTg-AD mice

(2015) Kurt R. Stover et al.   BEHAVIOURAL BRAIN RESEARCH

Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice

(2015) A. Rahimi et al.   NEUROSCIENCE

Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker

(2015) Zhihui Yang et al.   TRENDS IN NEUROSCIENCES

Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes

(2015) Luca Steardo et al.   Frontiers in Neuroscience

Glia in the pathogenesis of neurodegenerative diseases

(2014) Alexei Verkhratsky et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain

(2014) Daniela Impellizzeri et al.   Journal of Neuroinflammation

Reactive Gliosis and the Multicellular Response to CNS Damage and Disease

(2014) Joshua E. Burda et al.   NEURON

Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease

(2014) C Scuderi et al.   Cell Death & Disease

Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer’s disease

(2014) Caterina Scuderi et al.   Frontiers in Pharmacology

Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood

(2013) Henrik Zetterberg et al.   Nature Reviews Neurology

Therapeutics of Alzheimer's disease: Past, present and future

(2013) R. Anand et al.   NEUROPHARMACOLOGY

N-Palmitoylethanolamine depot injection increased its tissue levels and those of other acylethanolamide lipids

(2013) Peter Koulen et al.   Drug Design Development and Therapy

A network map of BDNF/TRKB and BDNF/p75NTR signaling system

(2013) Varot K. Sandhya et al.   Journal of Cell Communication and Signaling

Neurological Diseases as Primary Gliopathies: A Reassessment of Neurocentrism

(2012) Alexei Verkhratsky et al.   ASN Neuro

Glial cells in (patho)physiology

(2012) Vladimir Parpura et al.   JOURNAL OF NEUROCHEMISTRY

Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α

(2012) Caterina Scuderi et al.   Journal of Neuroinflammation

Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease

(2012) Giuseppe D'Agostino et al.   NEUROPSYCHOPHARMACOLOGY

Genetic Knockdown of Brain-Derived Neurotrophic Factor in 3xTg-AD Mice Does Not Alter Aβ or Tau Pathology

(2012) Nicholas A. Castello et al.   PLoS One

Neuroprotective Activities of Palmitoylethanolamide in an Animal Model of Parkinson's Disease

(2012) Emanuela Esposito et al.   PLoS One

The Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Prediction of Neural Risk for Alzheimer Disease

(2011) Aristotle N. Voineskos et al.   ARCHIVES OF GENERAL PSYCHIATRY

Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide

(2011) Caterina Scuderi et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease

(2010) Markel Olabarria et al.   GLIA

Mutant Huntingtin in Glial Cells Exacerbates Neurological Symptoms of Huntington Disease Mice

(2010) Jennifer Bradford et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Astrocytes in Alzheimer’s disease

(2010) Alexei Verkhratsky et al.   Neurotherapeutics

Astrocytes: biology and pathology

(2009) Michael V. Sofroniew et al.   ACTA NEUROPATHOLOGICA

White matter activated glial cells produce BDNF in a stroke model of monkeys

(2009) Yuki Sato et al.   NEUROSCIENCE RESEARCH

Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte

(2009) Pei-Chun Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Astroglia in dementia and Alzheimer's disease

(2008) J J Rodríguez et al.   CELL DEATH AND DIFFERENTIATION

S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells

(2008) Giuseppe Esposito et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE